1. Home
  2. LXFR vs SEPN Comparison

LXFR vs SEPN Comparison

Compare LXFR & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXFR
  • SEPN
  • Stock Information
  • Founded
  • LXFR 1898
  • SEPN 2022
  • Country
  • LXFR United States
  • SEPN United States
  • Employees
  • LXFR N/A
  • SEPN N/A
  • Industry
  • LXFR Major Chemicals
  • SEPN
  • Sector
  • LXFR Industrials
  • SEPN
  • Exchange
  • LXFR Nasdaq
  • SEPN NYSE
  • Market Cap
  • LXFR 295.8M
  • SEPN 311.6M
  • IPO Year
  • LXFR 2012
  • SEPN 2024
  • Fundamental
  • Price
  • LXFR $12.44
  • SEPN $6.73
  • Analyst Decision
  • LXFR
  • SEPN Buy
  • Analyst Count
  • LXFR 0
  • SEPN 4
  • Target Price
  • LXFR N/A
  • SEPN $33.00
  • AVG Volume (30 Days)
  • LXFR 123.2K
  • SEPN 193.7K
  • Earning Date
  • LXFR 04-29-2025
  • SEPN 05-23-2025
  • Dividend Yield
  • LXFR 4.21%
  • SEPN N/A
  • EPS Growth
  • LXFR 49063.50
  • SEPN N/A
  • EPS
  • LXFR 0.79
  • SEPN N/A
  • Revenue
  • LXFR $399,500,000.00
  • SEPN $1,075,000.00
  • Revenue This Year
  • LXFR $1.09
  • SEPN N/A
  • Revenue Next Year
  • LXFR $5.87
  • SEPN N/A
  • P/E Ratio
  • LXFR $15.70
  • SEPN N/A
  • Revenue Growth
  • LXFR 1.63
  • SEPN 611.92
  • 52 Week Low
  • LXFR $9.41
  • SEPN $4.17
  • 52 Week High
  • LXFR $15.64
  • SEPN $28.99
  • Technical
  • Relative Strength Index (RSI)
  • LXFR 70.28
  • SEPN N/A
  • Support Level
  • LXFR $10.67
  • SEPN N/A
  • Resistance Level
  • LXFR $11.81
  • SEPN N/A
  • Average True Range (ATR)
  • LXFR 0.43
  • SEPN 0.00
  • MACD
  • LXFR 0.27
  • SEPN 0.00
  • Stochastic Oscillator
  • LXFR 99.44
  • SEPN 0.00

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Share on Social Networks: